These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2317833)
21. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810 [TBL] [Abstract][Full Text] [Related]
22. Serum prealbumin, transferrin and alpha-1-acid glycoprotein in patients with gynecological carcinomas. Tosner J; Krejsek J; Louda B Neoplasma; 1988; 35(4):403-11. PubMed ID: 3141823 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856 [TBL] [Abstract][Full Text] [Related]
24. Serum levels of manganese superoxide dismutase in patients with localized scleroderma. Jinnin M; Ihn H; Yazawa N; Asano Y; Yamane K; Tamaki K Exp Dermatol; 2004 Jun; 13(6):357-60. PubMed ID: 15186321 [TBL] [Abstract][Full Text] [Related]
25. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay. Chien CH; Huang CC; Lin YH; Shen J; Chow SN Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253 [TBL] [Abstract][Full Text] [Related]
26. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors]. Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691 [TBL] [Abstract][Full Text] [Related]
27. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer. Suzuki M; Ohwada M; Aida I; Tamada T; Hanamura T; Nagatomo M Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270 [TBL] [Abstract][Full Text] [Related]
28. Serum evaluation of interleukin 6 in ovarian cancer patients. Tempfer C; Zeisler H; Sliutz G; Haeusler G; Hanzal E; Kainz C Gynecol Oncol; 1997 Jul; 66(1):27-30. PubMed ID: 9234916 [TBL] [Abstract][Full Text] [Related]
29. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB; Triratanachat S; Young RH; Oliva E Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [TBL] [Abstract][Full Text] [Related]
30. Elevation of the placental glutathione S-transferase form (GST-pi) in tumor tissues and the levels in sera of patients with cancer. Tsuchida S; Sekine Y; Shineha R; Nishihira T; Sato K Cancer Res; 1989 Sep; 49(18):5225-9. PubMed ID: 2504486 [TBL] [Abstract][Full Text] [Related]
31. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Klug TL; Bast RC; Niloff JM; Knapp RC; Zurawski VR Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078 [TBL] [Abstract][Full Text] [Related]
33. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies. Simpson J; Schlom J Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701 [TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors]. Peng XP; Li JD; Li MD; Ye XM; Yan WC Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of serum VEGF in women with ovarian tumors. Oehler MK; Caffier H Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186 [TBL] [Abstract][Full Text] [Related]
36. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Marklund SL; Westman NG; Lundgren E; Roos G Cancer Res; 1982 May; 42(5):1955-61. PubMed ID: 7066906 [TBL] [Abstract][Full Text] [Related]
37. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991 [TBL] [Abstract][Full Text] [Related]
38. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222 [TBL] [Abstract][Full Text] [Related]
39. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173 [TBL] [Abstract][Full Text] [Related]
40. Enzyme-linked immunosorbent assay for human and rat manganese superoxide dismutases. Suzuki K; Ookawara T; Miyamoto Y; Taniguchi N Methods Enzymol; 2002; 349():129-41. PubMed ID: 11912903 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]